Maxcyte (MXCT) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Maxcyte (MXCT) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | -54.61% |
| 10 | Maxcyte | 111.68 Mn | 111.68 Mn | 8.08 Mn | -460.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -460.58% |
| Dec 31, 2025 | 28.24% |
| Sep 30, 2025 | -272.43% |
| Jun 30, 2025 | -1,218.18% |
| Mar 31, 2025 | 91.44% |
| Dec 31, 2024 | 53.96% |
| Sep 30, 2024 | 71.68% |
| Jun 30, 2024 | 93.87% |
| Mar 31, 2024 | 25.59% |
| Dec 31, 2023 | -80.23% |
| Sep 30, 2023 | -490.23% |
| Jun 30, 2023 | -45.95% |
| Mar 31, 2023 | -4,326.73% |
| Dec 31, 2022 | -100.24% |
| Sep 30, 2022 | 98.79% |
| Jun 30, 2022 | 77.40% |
| Mar 31, 2022 | 99.99% |
| Dec 31, 2021 | 2,106.89% |
| Sep 30, 2021 | -278.51% |
| Jun 30, 2021 | -25.92% |